Breakthrough in Sepsis-Associated Lung Injury Research Yields Promising Results

Researchers from Naval Medical University have made a significant discovery in understanding the mechanisms behind sepsis-induced lung injury, a life-threatening condition. According to a new report, the gut-lung axis plays a critical role in the development of septic lung injury, and a novel treatment using oral manganese-doped carbon dots (Mn-CDs) has shown promising results in alleviating the condition.

Key Takeaways:

  • The gut-lung axis is a crucial pathway involved in sepsis-induced lung injury, with gut microbiota homeostasis being a key factor in the development of the condition.
  • Mn-CDs, a novel treatment, have been shown to alleviate septic lung injury by targeting the gut-lung axis and remodeling gut microbiota homeostasis.
  • Mn-CDs possess multienzyme mimetic activities and potent ROS scavenging capacity, making them a potential therapeutic agent for septic lung injury.
  • The researchers have identified indole-3-propionic acid (IPA) as a key mediator of the protective effects of Mn-CDs, which likely binds to the aryl hydrocarbon receptor (AHR) to promote efferocytosis and anti-inflammatory polarization in macrophages.
  • Fecal microbiota transplantation from Mn-CDs-treated mice has been shown to effectively promote efferocytic polarization of pulmonary macrophages in septic mice.

Statistics:

  • The incidence of sepsis-induced lung injury is a significant global health challenge, with poorly defined pathological mechanisms.
  • Mn-CDs have been shown to significantly improve systemic indices and alleviate septic lung injury in murine models.
  • The researchers have identified 12 differentially expressed genes in the gut microbiota of Mn-CDs-treated mice, including the enrichment of and concomitant with elevated IPA production.

Sources:

  • NewsRx. New Lung Injury Findings from Naval Medical University Discussed (Oral Multi-Enzymatic Manganese-Carbon Dots Alleviate Sepsis-Associated Lung Injury via the Gut-Lung Axis). Respiratory Therapeutics Week. November 3, 2025; p 3603.
  • ACS Nano. Oral Multi-Enzymatic Manganese-Carbon Dots Alleviate Sepsis-Associated Lung Injury via the Gut-Lung Axis. 2025.
  • Amer Chemical Soc, 1155 16TH St, NW, Washington, DC 20036, USA. (American Chemical Society - www.acs.org; ACS Nano - www.pubs.acs.org/journal/ancac3)